SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats

Free Radical Biology and Medicine

Volumn 47, Issue 7, 2009, Pages 1067-1074

  Aragno, Manuela ^a   Tomasinelli, Chiara E ^a   Vercellinatto, Ilenia ^a   Catalano, Maria G ^a   Collino, Massimo ^a   Fantozzi, Roberto ^a   Danni, Oliviero ^a   Boccuzzi, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Dehydroepiandrosterone; High fat diet plus fructose; Insulin resistance; Nonalcoholic fatty liver disease; Oxidative stress; Sterol regulatory element binding protein 1c

Indexed keywords

FRUCTOSE; INSULIN RECEPTOR SUBSTRATE 2; LIVER PROTEIN; LIVER X ACTIVATED RECEPTOR ALPHA; PRASTERONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; INSULIN RESISTANCE; LIPID DIET; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT;

ANIMALS; CELL DEATH; DEHYDROEPIANDROSTERONE; DIETARY FATS; FATTY LIVER; FRUCTOSE; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

RATTUS; RATTUS NORVEGICUS;

EID: 69249239041     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.016     Document Type: Article

References (49)

1. Erickson S.K. Nonalcoholic fatty liver disease. J. Lipid Res. 50 (2008) S412-S416 (Suppl.)
2. Vuppalanchi R., and Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49 (2009) 306-317
3. Tilg H., and Hotamisligil G.S. Non alcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131 (2006) 934-994
4. Die C.P., and James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
5. Capeau J. Insulin resistance and steatosis in humans. Diabetes Metab. 34 (2008) 649-657
6. Ahmed M.H., and Byrne C.D. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discovery Today 12 (2007) 740-747
7. Cagen L.M., Deng X., Wilcox H.G., Park E.A., Raghow R., and Elam M.B. Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem. J. 385 (2005) 207-216
8. Shimano H. SREBPs: physiology and pathophysiology of the SREBP family. FEBS J. 276 (2009) 616-621
9. Schaalan M., El-Abhar H.S., Barakat M., and El-Denshary E.S. Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride. J. Diabetes Complications 23 (2008) 199-208
10. Deng J.Y., Huang J.P., Lu L.S., and Hung L.M. Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H978-987
11. Brignardello E., Runzo C., Aragno M., Catalano M.G., Cassader M., Perin P.C., and Boccuzzi G. Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients. Diabetes Care 30 (2007) 2922-2927
12. Aragno M., Mastrocola R., Alloatti G., Vercellinatto I., Bardini P., Geuna S., Catalano M.G., Danni O., and Boccuzzi G. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149 (2008) 380-388
13. Aoki K., Nakajima A., Mukasa K., Osawa E., Mori Y., and Sekihara H. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone. J. Steroid Biochem. Mol. Biol. 85 (2003) 469-472
14. Brignardello E., Gallo M., Aragno M., Manti R., Tamagno E., Danni O., and Boccuzzi G. Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells. J. Endocrinol. 166 (2000) 401-406
15. Charlton M., Angulo P., Chalasani N., Merriman R., Viker K., Charatcharoenwitthaya P., Sanderson S., Gawrieh S., Krishnan A., and Lindor K. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology 47 (2008) 484-492
16. Pérez de Heredia F., Larque E., Zamora S., and Garaulet M.D. modifies rat fatty acid composition of serum and different adipose tissue depots and lowers serum insulin levels. J. Endocrinol. (2009) 10.1677/JOE-08-0432
17. Berdanier C.D., Parente Jr. J.A., and McIntosh M.K. Is dehydroepiandrosterone an antiobesity agent?. FASEB J. 7 (1993) 414-419
18. Meldrum D.R., Shenkar R., Sheridan B.C., Cain B.S., Abraham E., and Harken A.H. Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J. Mol. Cell. Cardiol. 29 (1997) 2849-2854
19. Bradford M.A. rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72 (1976) 248-254
20. Zoccorato F., Deana R., Cavallini L., and Alexandre A. Generation of hydrogen peroxide by cerebral cortex synaptosomes. Eur. J. Biochem. 180 (1989) 473
21. Owens C.W.I., and Belcher R.V.A. colorimetric micro-method for the determination of glutathione. Biochem. J. 94 (1965) 705-709
22. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
23. Flohé L., and Otting F. Superoxide dismutase assays. Methods Enzymol. 105 (1984) 93-104
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
25. Mastrocola R., Aragno M., Betteto S., Brignardello E., Catalano M.G., Danni O., and Boccuzzi G. Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. Life Sci. 73 (2003) 289-299
26. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., Ota T., Yokoyama M., Honda M., Miyamoto K., and Kaneko S. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57 (2008) 1071-1077
27. Karin M. How NFκB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18 (1999) 6867-6874
28. Ide T., Shimano H., Yahagi N., Matsuzaka T., Nakakuki M., Yamamoto T., Nakagawa Y., Takahashi A., Suzuki H., Sone H., Toyoshima H., Fukamizu A., and Yamada N. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat. Cell Biol. 6 (2004) 351-357
29. Marra F., Gastaldelli A., Svegliati Baroni G., Tell G., and Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 14 (2008) 72-81
30. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., and Demeure O. Fatty acid regulation of hepatic gene transcription. J. Nutr. 135 (2005) 2503-2506
31. Haber C.A., Lam T.K., Yu Z., Gupta N., Goh T., Bogdanovic E., Giacca A., and Fantus I.G. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E744-753
32. Sekiya M., Hiraishi A., Touyama M., and Sakamoto K. Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem. Biophys. Res. Commun. 375 (2008) 602-607
33. Ulven S.M., Dalen K.T., Gustafsson J.A., and Nebb H.I.L. is crucial in lipid metabolism. Prostaglandins Leukotrienes Essent. Fatty Acids 73 (2005) 59-63
34. Liang G., Yang J., Horton J.D., Hammer R.E., Goldstein J.L., and Brown M.S. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277 (2002) 9520-9528
35. Cerf M.E. High fat diet modulation of glucose sensing in the beta-cell. Med. Sci. Monit. 13 (2007) RA12-RA17
36. Manco M., and Bottazzo G. Does the hormone of eternal youth protect against non alcoholic steatohepatitis?. Hepatology 48 (2008) 1351
37. Sánchez J., Pérez de Heredia F., Priego T., Portillo M.P., Zamora S., Garaulet M., and Palou A. Dehydroepiandrosterone prevents age-associated alterations, increasing insulin sensitivity. J. Nutr. Biochem. 19 (2008) 809-818
38. Schaeffler A., Gross P., Buettner R., Bollheimer C., Buechler C., Neumeier M., Kopp A., Schoelmerich J., and Falk W. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126 (2009) 233-245
39. Iwasaki Y., Asai M., Yoshida M., Nigawara T., Kambayashi M., and Nakashima N. Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J. Clin. Endocrinol. Metab. 89 (2004) 3449-3454
40. Aragno M., Cutrin J.C., Mastrocola R., Perrelli M.G., Restivo F., Poli G., Danni O., and Boccuzzi G. Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. Kidney Int. 64 (2003) 836-843
41. Aragno M., Parola S., Brignardello E., Mauro A., Tamagno E., Manti R., Danni O., and Boccuzzi G. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 49 (2000) 1924-1931
42. Pérez de Heredia F., Sánchez J., Priego T., Nicolás F., Portillo Mdel P., Palou A., Zamora S., and Garaulet M. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats. Steroids 73 (2008) 1128-1136
43. Matsuda A., Furukawa K., Suzuki H., Matsutani T.M., Tajiri T., and Chaudry I.H. Dehydroepiandrosterone modulates toll-like receptor expression on splenic macrophages of mice after severe polymicrobial sepsis. Shock 24 (2005) 364-369
44. Boccuzzi G., Brignardello E., di Monaco M., Forte C., Leonardi L., and Pizzini A. Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol. Anticancer Res. 12 (1992) 799-803
45. Brignardello E., Beltramo E., Molinatti P.A., Aragno M., Gatto V., Tamagno E., Danni O., Porta M., and Boccuzzi G. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J. Endocrinol. 158 (1998) 21-26
46. Jiang Y., Miyazaki T., Honda A., Hirayama T., Yoshida S., Tanaka N., and Matsuzaki Y. Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone. J. Gastroenterol. 40 (2005) 490-497
47. Liu D., Si H., Reynolds K.A., Zhen W., Jia Z., and Dillon J.S. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148 (2007) 3068-3076
48. Tang X., Ma H., Zou S., and Chen W. Effects of dehydroepiandrosterone (DHEA) on hepatic lipid metabolism parameters and lipogenic gene mRNA expression in broiler chickens. Lipids 42 (2007) 1025-1033
49. Adams L.A., Feldstein A., Lindor K.D., and Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 39 (2004) 909-914